Acorda Therapeutics
ACOR
#10358
Rank
S$1.06 M
Marketcap
$0.86
Share price
0.00%
Change (1 day)
-95.82%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -S$0.36 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are S$0.11 Billion. In 2023 the company made an earning of -S$0.35 Billion a decrease over its 2022 earnings that were of -S$6.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.36 Billion4.53%
2023 -S$0.35 Billion4848.63%
2022 -S$6.96 Million-93.25%
2021 -S$0.11 Billion2.52%
2020 -S$0.11 Billion-69.45%
2019 -S$0.33 Billion-700.62%
2018 S$54.73 M-118.02%
2017 -S$0.31 Billion805.99%
2016 -S$33.54 Million-173.88%
2015 S$45.38 M-6.58%
2014 S$48.58 M20.19%
2013 S$40.42 M18.7%
2012 S$34.05 M-26.54%
2011 S$46.35 M
2009 -S$0.11 Billion10.65%
2008 -S$95.68 Million86.17%
2007 -S$51.39 Million68.1%
2006 -S$30.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$8.22 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.70 B-299.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$99.68 Million-71.85%๐Ÿ‡ฉ๐Ÿ‡ช Germany
S$0.33 B-195.95%๐Ÿ‡บ๐Ÿ‡ธ USA